The RESTORE Study

20111,316 citationsJournal Articlehybrid Open Access

Authors

Paul Mitchell · Westmead Institute

Francesco Bandello · Vita-Salute San Raffaele University

Ursula Schmidt‐Erfurth · University of Vienna

Gabriele E. Lang · University Hospital Ulm

Pascale Massin · Hôpital Lariboisière

Reinier O. Schlingemann · Academic Center for Dentistry Amsterdam

Florian Sutter

Abstract

Ranibizumab monotherapy and combined with laser provided superior visual acuity gain over standard laser in patients with visual impairment due to DME. Visual acuity gains were associated with significant gains in VFQ-25 scores. At 1 year, no differences were detected between the ranibizumab and ranibizumab + laser arms. Ranibizumab monotherapy and combined with laser had a safety profile in DME similar to that in age-related macular degeneration.

Topics & Keywords

Retinal Diseases and Treatments Glaucoma and retinal disorders Retinal Imaging and Analysis

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Ophthalmology

Volume 118, Issue 4, pp. 615-625

DOI: 10.1016/j.ophtha.2011.01.031

Field-Weighted Citation Impact: 84.59